Keynote Speakers
Danilo Tagle Director, Office of Special Initiatives, National Center for Advancing Translational Sciences at the NIH (NCATS) |
Michael Heller Professor, Dept Bioengineering, University of California-San Diego |
Martyn Boutelle Professor of Biomedical Sensors Engineering, Imperial College London |
Valérie Taly CNRS Research Director, Professor and Group leader Translational Research and Microfluidics, Université Paris Cité |
OverviewWelcome to the SelectBIO Annual Point-of-Care & Rapid Diagnostics 2022 Conference to be held in-person on-site at the Hilton Long Beach - Long Beach, California. Bringing together researchers and industry participants from both
academia and industry, this established event,
will discuss the latest innovations and developments in the Lab-on-a-Chip (LOAC) and Microfluidics fields as they impact POC & Rapid Dx. Emphasis placed on SARS-CoV-2 Rapid Dx and Technology Approaches and Themes: Lateral Flow and Beyond. There
is an Extensive International Perspective at this Conference with
Speakers, Poster Presenters, Sponsors, and Exhibitors from the US,
Europe, and Asia/Pacific. Running alongside the conference will
be an exhibition covering the latest technological advances and
associated products and services from leading solution providers within
this field from around the world. Registered delegates will have full
access to the co-located and concurrent tracks and sessions to
mix-and-match presentations and maximize networking: - Lab-on-a-Chip and Microfluidics: Techologies, Companies and Commercialization 2022
- Point-of-Care & Rapid Diagnostics: SARS-CoV-2 and Beyond 2022
- Organoids and Microphysiological Systems 2022
- Extracellular Vesicles (EVs): Technologies & Biological Investigations 2022
There is a extensive exhibit hall featuring companies from these fields enabling business development, partnering and networking. Extensive networking opportunities available over the course of this 2.5-day conference.
Agenda Topics- 3D-Printed Sensors and Technology Development in Sensors Field
- Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
- Low-Cost POC Devices for Deployment Worldwide in Resource-Limited Settings
- Microfluidics for Wearables and Mobile Diagnostics Development
- Next Generation Sequencing for Pathogen Detection: Case Studies with SARS-CoV-2
- POC Diagnostics in Infectious Disease Testing: Emphasis on SARS-CoV-2 Testing
Sponsorship and Exhibition OpportunitiesJeff Fan, Exhibition Manager jeff@selectbioconferences.com +1-510-857-4865
|
Confirmed Speakers to dateSagar Bhagwat, Research Fellow, Albert-Ludwigs-University of Freiburg, Department of Microsystems Engineering (IMTEK) Claudia Gärtner, CEO, microfluidic ChipShop GmbH Satomi Hirose, PhD Candidate and Researcher, Tohoku University, Graduate School of Biomedical Engineering Mehran Mansouri, Researcher, Rochester Institute of Technology Arben Merkoçi, ICREA Professor and Director of the Nanobioelectronics & Biosensors Group, Institut Català de Nanociencia i Nanotecnologia (ICN2), Barcelona Institute of Science and Technology (BIST) Wilhelm Meyer, Managing Director, Microdrop Technologies GmbH Rob Rich, Director of Sales, North America (West), BioDot, Inc.
|
|
Corporate Sponsors
|
Media Sponsors
|
Official Journal Partner
|
Networking
|
|
|
|
|
|